Ventyx Biosciences to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Rhea-AI Summary

Ventyx Biosciences, Inc. (Nasdaq: VTYX) announces participation in the Oppenheimer 34th Annual Healthcare Life Sciences Conference. The clinical-stage biopharmaceutical company focuses on advancing novel oral therapies for inflammatory diseases with significant unmet medical need. The event will be held virtually on February 13, 2024, with a webcast available on the Ventyx website.

SAN DIEGO, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that Company executives will participate in the upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference.

• Event: Oppenheimer 34th Annual Healthcare Life Sciences Conference 
  Location: Virtual
  Date: Tuesday, February 13, 2024
  Time: 11:20-11:50 AM ET

A webcast of the presentation will be available in the Investors and News section of the Ventyx website at www.ventyxbio.com. A webcast replay will also be available on this website shortly after conclusion of the event for thirty days.

About Ventyx Biosciences

Ventyx is a clinical-stage biopharmaceutical company focused on developing innovative oral medicines for patients living with autoimmune and inflammatory disorders. We believe our ability to efficiently discover and develop differentiated drug candidates will allow us to address important unmet medical need with novel oral therapies that can shift immunology markets from injectable to oral drugs. Our current pipeline includes internally discovered clinical programs targeting TYK2, S1P1R and NLRP3, positioning us to become a leader in the development of oral immunology therapies. Ventyx is headquartered in San Diego, California. For more information about Ventyx, please visit www.ventyxbio.com.

Investor Relations Contact
Patti Bank
Managing Director
ICR Westwicke
(415) 513-1284
IR@ventyxbio.com

FAQ

What is the ticker symbol for Ventyx Biosciences, Inc.?

The ticker symbol for Ventyx Biosciences, Inc. is VTYX.

What is the focus of Ventyx Biosciences, Inc.?

Ventyx Biosciences, Inc. is focused on advancing novel oral therapies for a broad range of inflammatory diseases with significant unmet medical need.

When and where will the Oppenheimer 34th Annual Healthcare Life Sciences Conference take place?

The Oppenheimer 34th Annual Healthcare Life Sciences Conference will be held virtually on February 13, 2024.

Where can the webcast of the presentation be accessed?

The webcast of the presentation will be available in the Investors and News section of the Ventyx website at www.ventyxbio.com.

Will a webcast replay be available after the event?

Yes, a webcast replay will be available on the Ventyx website shortly after the conclusion of the event for thirty days.